tradmap

NEPH NEPHROS INC

$3.17 -1.55%

Healthcare · Surgical & Medical Instruments & Apparatus

NEPHROS INC (NEPH) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $34 million. Shares last traded at $3.17, 48.2% below their 52-week high. Over the past year the stock is up 2.6%. NEPH trades at a price-to-earnings ratio of 28.82, in line with the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 6.4%, above the peer median of -7.6%. Revenue grew 32.7% year over year.

Market Cap
$34M
Shares Out
10.9M
EPS (TTM)
$0.23
P/E Ratio
13.78
P/S Ratio
1.83
P/B Ratio
3.22
Dividend / Share
Dividend Yield
52-Week High
$6.13
52-Week Low
$2.75
Volume
29
Avg Vol (3m)
621.921

Performance

1W
-4.08%
1M
-12.67%
3M
-15.01%
6M
-33.96%
YTD
-35.31%
1Y
+2.59%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
44.02
SMA (50)
$3.22
SMA (200)
$4.19
Price vs SMA50
-1.51%
Price vs SMA200
-24.40%
ATR (14)
$0.15

Financials

Revenue
$19M
Net Income
$1M
Gross Margin
61.9%
Operating Margin
6.1%
Net Margin
6.4%
Return on Equity
11.2%
Return on Assets
8.7%
Current Ratio
4.55
Debt / Equity
0.01
Revenue Growth (YoY)
+32.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.01 2026-05-07
FY 2025 $0.11 2026-03-12
Q3 2025 $0.10 2025-11-06
Q2 2025 $0.07 2025-08-07
Q1 2026 $0.05 2026-05-07
FY 2025 $0.01 2026-03-12

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NEPH vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers
28.82 / 28.73 med
+0% premium
P/S vs peers
1.83 / 2.52 med
-27% discount
Net margin vs peers
6.4% / -7.6% med
above median
1–14 of 14
SYKStryker Corporation$118.1B36.384.7012.9%+2.28%
MMM3M$83.9B25.823.3613.0%+1.10%
BSXBoston Scientific$67.3B23.273.3514.4%+0.64%
BDXBecton Dickinson$39.7B23.641.827.7%+1.62%
MDLNMedline Inc.$29.4B-1.47%
DXCMDexCom$28.0B33.436.0017.9%+1.69%
RMDResMed$27.4B19.535.3227.2%+1.24%
WSTWest Pharmaceutical Services$23.2B46.927.5416.1%+1.35%
SOLVSolventum$13.1B+1.21%
PENPenumbra Inc$12.5B70.188.8812.7%+0.28%
GMEDGlobus Medical Inc$10.8B19.993.6618.3%+5.00%
BAXBaxter International$10.3B-10.740.91-8.5%+2.58%
PODDInsulet Corporation$10.1B40.843.739.1%+1.51%
GKOSGlaukos Corp$7.7B-40.9215.13-37.0%+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.